About Dr. Adam
I’m a board-certified psychiatrist who works closely with adults seeking clarity, balance, and a renewed sense of well-being. My approach is collaborative and discreet, blending thoughtful medication management with supportive psychotherapy. I’ve cared for patients in a wide range of settings, from academic medical centers to private practice, and I believe the most meaningful results come from a personalized and steady partnership.
Training & Background
Residency: Psychiatry, NewYork-Presbyterian/Weill Cornell (Payne Whitney)
Internship: Dartmouth
Medical School: Saint Louis University School of Medicine
Graduate: M.Sc., Imperial College London
Undergraduate: B.S., Columbia University
Clinical Work: NYU Langone & Bellevue
Licensure: New York & California · Board Certified, ABPN
Publications & Research
My academic work has focused on psychopharmacology, neuroscience, and data-driven health outcomes. I’ve authored and coauthored publications in both clinical and translational psychiatry, including a textbook chapter for the American Psychiatric Association Publishing Textbook of Psychiatry.
Selected publications:
Avery J, Adam T, Levounis P. Substance-Related and Addictive Disorders. In: Roberts LW, ed. The American Psychiatric Association Publishing Textbook of Psychiatry. 7th ed. Washington, DC: APA Publishing; 2019.
Mermelstein AC, Mermelstein J, Adam T, Brody BD, Dubin MJ. Oxcarbazepine-induced liver injury after sensitization by valproic acid: a case report. Bipolar Disorders. 2016;18(3):307–309.
Schmidt S, Schenkova K, Adam T, Erikson E, Lehmann-Koch J, Sertel S, Verhasselt B, Fackler OT, Keppler OT. SAMHD1’s protein expression profile in humans. Journal of Leukocyte Biology. 2015;98(1):5–14.
Erikson E, Adam T, Schmidt S, Lehmann-Koch J, Over B, Goffinet C, et al. In vivo expression profile of the antiviral restriction factor and tumor-targeting antigen CD317/BST-2/HM1.24/tetherin in humans. PNAS.2011;108(33):13688–13693.
Ghosh D, Cabrera J, Adam TN, Levounis P, Adam NR. Comorbidity patterns and their impact on health outcomes: two-way clustering analysis. IEEE Transactions on Big Data. 2020;6(2):359–368.